Claudio Bona

Lymphoblastic Leukemia (all) Molecular Study of Minimal Residual Disease (mrd) in Adult Acute Improved Risk Classification for Risk-specific Therapy Based on The

T. Barbui, A. Bosi, A. Gallamini, 2022 .